Fujifilm is at the forefront of the digital histopathology revolution, centred around the Dynamyx software by Inspirata, and supported by partnerships that drive improvements in patient care.
end-to-end digital histopathology solution with absolute open architecture, allowing seamless integration with many scanners and laboratory information management systems. It combines workflow and case management tools with image evaluation and AI solutions into one highly functional and user-friendly package. This dedicated pathology platform is specifically designed for pathologists and laboratory teams, and can combine with Fujifilm’s PACS solution, Synapse, to unify image data across enterprises and support clinical decision making.
Digital solutions offer significant logistical and operational benefits and can ease the burden on the declining number of histopathologists under increasing demand. Digitising images unlocks immense collaborative possibilities, as results can be reviewed by other specialists or educational institutions in real time, worldwide, improving the time to diagnosis and prognosis.
Combining this with AI solutions – that use objective, quantitative data – facilitates even faster, and more accurate and consistent clinical decisions. Fujifilm’s goal is to make this transition as seamless as possible, tailoring its solutions to the needs of each customer, and allocating dedicated project managers and application specialists to engage with pathologists during the process.
Tim Wing, Head Of Digital Pathology at FUJIFILM Corporation, explained: “We have a long history in the healthcare sector, and we are very excited to be part of the digital pathology revolution. Combining Dynamyx, a best-in-class software, with our synergistic suite of products and dedicated and experienced team will help get images in the hands of the right person quicker, supporting rapid diagnosis and, ultimately, better patient outcomes.”